Skip to Content
You are currently on the new version of our website. Access the old version .
CancersCancers
  • Systematic Review
  • Open Access

26 October 2025

28 Pages

Comparative Effectiveness of Interventions to Treat Cancer Treatment-Related Cognitive Impairment in Adult Cancer Survivors Following Systemic Therapy: A Systematic Review with Network Meta-Analyses

,
,
,
,
,
,
,
,
…
1
Methodological and Implementation Research Program, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada
2
Neuroscience Program, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada
3
Brain and Mind Research Institute, University of Ottawa, Ottawa, ON K1H 8M5, Canada
4
Center for Evidence Synthesis in Health, Department of Health Services, Policy, and Practice, School of Public Health, Brown University, Providence, RI 02912, USA

Simple Summary

Many cancer survivors experience lasting problems with memory, attention, and other aspects of cognitive functioning after chemotherapy or other systemic treatments—often referred to as cancer treatment-related cognitive impairment (CTRCI). To better understand which treatments may help, we reviewed evidence from randomized controlled trials testing psychological, pharmacological, and other interventions for adults with established CTRCI. Across 18 studies, a structured, therapist-led group program that combined patient education with cognitive rehabilitation showed the most consistent benefits, improving several areas of thinking and memory, while mindfulness-based interventions also showed some positive effects. In contrast, medications such as donepezil did not show benefit. Although the evidence remains limited and of low certainty, these findings suggest that group-based rehabilitation programs may offer the most promise for improving cognitive function in cancer survivors.

Abstract

Background. Cancer treatment-related cognitive impairment (CTRCI) is a frequent and persistent consequence of systemic cancer therapy, adversely affecting quality of life and independence among cancer survivors. Methods. To clarify the relative effectiveness of available treatments, we conducted a systematic review and network meta-analyses of randomized controlled trials evaluating psychological, pharmacological, and other interventions for established CTRCI in adult survivors of non-central nervous system cancers. Eligible trials reported objective outcomes in one or more of eight cognitive domains, including learning, memory, processing speed, word generation, cognitive flexibility, attention, working memory, and abstraction. Results. Eighteen studies met inclusion criteria, with 14 trials (n = 1100) contributing to network meta-analyses of immediate post-intervention effects across seven domains. A therapist-guided group intervention combining patient education and cognitive rehabilitation consistently ranked highest and was associated with significantly improved learning, memory, processing speed, attention, and working memory compared with a waitlist control, although the certainty of evidence (CoE) was low to very low and largely based on a single trial. Mindfulness-based interventions were also associated with improved processing speed (low CoE). Donepezil was associated with no benefit versus placebo for any domain. Conclusions. While findings suggest that structured multimodal group interventions may represent the most promising strategy for CTRCI, CoE was low, and additional rigorous, standardized trials are required.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.